Clinical use of rituximab in haematological malignancies.

Avivi, I; Robinson, S; Goldstone, A

Avivi, I; Robinson, S; Goldstone, A.

Affiliation

Avivi I; University College London Hospital, UK.

Br J Cancer ; 89(8): 1389-94, 2003 Oct 20.

Article in En | MEDLINE | ID: mdl-14562003

Subject(s)

Antibodies, Monoclonal/pharmacology; Antineoplastic Agents/pharmacology; Hematologic Neoplasms/drug therapy; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/adverse effects; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Clinical Trials as Topic; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Drug Administration Schedule; Humans; Peripheral Blood Stem Cell Transplantation; Prednisone/administration & dosage; Rituximab; Vincristine/administration & dosage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / Antibodies, Monoclonal / Antineoplastic Agents Limits: Humans Language: En Journal: Br J Cancer Year: 2003 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google